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Abstract The current epidemic of artemisinin resistant Plasmodium falciparum in Southeast Asia
is the result of a soft selective sweep involving at least 20 independent kelch13 mutations. In a
large global survey, we find that kelch13 mutations which cause resistance in Southeast Asia are
present at low frequency in Africa. We show that African kelch13 mutations have originated locally,
and that kelch13 shows a normal variation pattern relative to other genes in Africa, whereas in
Southeast Asia there is a great excess of non-synonymous mutations, many of which cause radical
amino-acid changes. Thus, kelch13 is not currently undergoing strong selection in Africa, despite a
deep reservoir of variations that could potentially allow resistance to emerge rapidly. The practical
implications are that public health surveillance for artemisinin resistance should not rely on kelch13
data alone, and interventions to prevent resistance must account for local evolutionary conditions,
shown by genomic epidemiology to differ greatly between geographical regions.
DOI: 10.7554/eLife.08714.001
Introduction
Artemisinin combination therapy (ACT), the frontline treatment for P. falciparum infection, has
played a major part in reducing the number of deaths due to malaria over the past decade
(World Health Organization, 2014b). However the increasing prevalence of artemisinin resistant P.
falciparum across large parts of Southeast Asia threatens to destabilise malaria control worldwide
(Dondorp et al., 2009; Hien et al., 2012; Phyo et al., 2012; Kyaw et al., 2013; Ashley et al.,
2014; World Health Organization, 2014a). One of the main contemporary challenges in global
health is to prevent artemisinin resistance from becoming established in Africa, where the conse-
quences for childhood mortality could be disastrous (Dondorp and Ringwald, 2013).
Understanding the epidemiological and evolutionary driving forces behind artemisinin resistance
is essential to develop effective strategies to stop it spreading. At the molecular level, artemisinin
resistance is caused by mutations in a kelch protein encoded by PF3D7_1343700 on P. falciparum
chromosome 13, referred to here as kelch13. More specifically, non-synonymous mutations in the
kelch13 propeller and BTB-POZ domains (KPBD) result in reduced sensitivity of P. falciparum to arte-
misinin, as demonstrated by multiple lines of evidence including laboratory studies of artificially
acquired resistance, genetic association studies of natural resistance and allelic replacement experi-
ments (Ariey et al., 2014; Ghorbal et al., 2014; Miotto et al., 2015; Straimer et al., 2015; Takala-
Harrison et al., 2015). Parasites with KBPD mutations tend to grow more slowly in the early part of
the erythrocytic cycle, and have an enhanced unfolded protein response, both of which might act to
protect against oxidative damage caused by artemisinin (Dogovski et al., 2015; Mok et al., 2015).
It has also recently been shown that the PI3K protein is the target of artemisinin action, and that
kelch13 binds to PI3K to mark it for degradation; by affecting this binding, KBPD mutations result in
high levels of PI3K which counteract the effect of artemisinin (Mbengue et al., 2015).
A striking characteristic of the current distribution of artemisinin resistance is that it is caused by
multiple independent KPBD mutations emerging in different locations, i.e. it does not originate from
a single mutational event. More than 20 KPBD SNPs have been associated with delayed parasite
clearance during artemisinin treatment and there are several documented instances of the same
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allele arising independently in different locations (Ashley et al., 2014; Miotto et al., 2015; Takala-
Harrison et al., 2015). These are classic features of a soft selective sweep which, according to evolu-
tionary theory, is most likely to arise in populations where the selected alleles are already present as
standing genetic variations or have been repeatedly introduced by de novo mutations
(Hermisson and Pennings, 2005; Pennings and Hermisson, 2006; Messer and Petrov, 2013).
There is ongoing debate among evolutionary biologists about how commonly soft selective sweeps
occur in nature (Jensen, 2014; Garud et al., 2015) but they have clearly played a role in previous
forms of antimalarial drug resistance (Nair et al., 2007; Salgueiro et al., 2010) and the current epi-
demic of artemisinin resistance is the most extreme example of a soft selective sweep thus far
observed in eukaryotes.
This creates a practical problem in monitoring the global spread of resistance. Artemisinin resis-
tance can be measured directly, by following the rate of parasite clearance in patients (Flegg et al.,
2011) or by testing parasite isolates in vitro (Witkowski et al., 2013), but these phenotypic assays
are resource intensive and impractical for large-scale screening in resource-poor settings. Genetic
approaches are therefore preferable for practical implementation of large-scale surveillance, but the
soft selective sweep of artemisinin resistance produces much more heterogeneous genetic signa-
tures than previous global waves of chloroquine and pyrimethamine resistance, where hard selective
sweeps were the dominant mode of spread. Thus there is considerable uncertainty about the epide-
miological significance of the growing number of non-synonymous KPBD mutations reported in
Africa (Ashley et al., 2014; Hopkins Sibley, 2015; Kamau et al., 2015; Taylor et al., 2015). Previ-
ous studies in Africa have not identified variants known to cause resistance in Southeast Asia
(Kamau et al., 2015; Taylor et al., 2015). At the same time, there are documented instances of Afri-
can parasites that can be rapidly cleared by artemisinin treatment, although they carry KPBD muta-
tions (Ashley et al., 2014). In the absence of comprehensive phenotypic data, it is not known which
of these mutations, if any, are markers of resistance. This is a limitation of conventional molecular
epidemiology, which tracks specific mutations and haplotypes and is poorly equipped to monitor
eLife digest Malaria is an infectious disease caused by a microscopic parasite called
Plasmodium, which is transferred between humans by mosquitos. One species of malaria parasite
called Plasmodium falciparum can cause particularly severe and life-threatening forms of the disease.
Currently, the most widely used treatment for P. falciparum infections is artemisinin combination
therapy, a treatment that combines the drug artemisinin (or a closely related molecule) with another
antimalarial drug. However, resistance to artemisinin has started to spread throughout Southeast
Asia.
Artemisinin resistance is caused by mutations in a parasite gene called kelch13, and researchers
have identified over 20 different mutations in P. falciparum that confer artemisinin resistance. The
diversity of mutations involved, and the fact that the same mutation can arise independently in
different locations, make it difficult to track the spread of resistance using conventional molecular
marker approaches.
Here, Amato, Miotto et al. sequenced the entire genomes of more than 3,000 clinical samples of
P. falciparum from Southeast Asia and Africa, collected as part of a global network of research
groups called the MalariaGEN Plasmodium falciparum Community Project. Amato, Miotto et al.
found that African parasites had independently acquired many of the same kelch13 mutations that
are known to cause resistance to artemisinin in Southeast Asia. However the kelch13 mutations seen
in Africa remained at low levels in the parasite population, and appeared to be under much less
pressure for evolutionary selection than those found in Southeast Asia.
These findings demonstrate that the emergence and spread of resistance to antimalarial drugs
does not depend solely on the mutational process, but also on other factors that influence whether
the mutations will spread in the population. Understanding how this is affected by different patterns
of drug treatments and other environmental conditions will be important in developing more
effective strategies for combating malaria.
DOI: 10.7554/eLife.08714.002
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soft selective sweeps where new mutations are continually arising on different haplotypic back-
grounds, making it difficult to keep track of their phenotypic effects and evolutionary trajectories.
Here we explore how genomic data might help overcome these practical obstacles to monitoring
the current epidemic of artemisinin resistance. This analysis includes genome sequencing data for
3,411 clinical samples of P. falciparum obtained from 43 locations in 23 countries. This large dataset
was generated by the MalariaGEN Plasmodium falciparum Community Project, (www.malariagen.
net/projects/parasite/pf), a collaborative study in which multiple research groups working on differ-
ent scientific questions are sharing genome variation data to generate an integrated view of poly-
morphism in the global parasite population. Data resources arising from the present analysis,
including genotype calls and sample metadata, can be obtained at www.malariagen.net/resource/
16. The MalariaGEN Plasmodium falciparum Community Project also developed a user-friendly web
application, with interactive tools for exploring and querying the latest version of the data: www.
malariagen.net/apps/pf.
Results
Africa and Southeast Asia both have many kelch13 polymorphisms
Paired-end sequence reads were generated using the Illumina platform and aligned to the P. falcipa-
rum 3D7 reference genome, applying a series of quality control filters as previously described (see
Materials and methods) (Manske et al., 2012; Miotto et al., 2013). The initial alignments identified
4,305,957 potential SNPs, which after quality control filtering produced a set of 935,601 exonic
SNPs that could be genotyped with high confidence in the majority of samples, and that form the
basis for the current analysis.
As summarised in Table 1, the dataset comprised 1,648 samples from Africa and 1,599 samples
from Southeast Asia, allowing us to compare these two groups directly without the need for sample
size corrections. We identified a total of 155 SNPs in the kelch13 gene, of which 128 were seen in
Africa and 62 in Southeast Asia (Table 2). Studies in Southeast Asia have found that artemisinin resis-
tance is associated with non-synonymous polymorphisms in the KPBD. Out of a total of 46 non-syn-
onymous SNPs in these domains we found a similar number in Africa (n = 26) and Southeast Asia
(n = 34), with 14 seen in both places (Table 3). Seven of those observed in Africa have previously
been associated with artemisinin resistance in Southeast Asia, including C580Y, the most common
allele in resistant parasites (Miotto et al., 2015).
kelch13 polymorphisms in Africa appear to be indigenous
We asked whether kelch13 polymorphisms seen in Africa had emerged independently, as opposed
to migrating from Southeast Asia. We started by grouping samples according to genome-wide
genetic similarity, based on a neighbour-joining (NJ) tree (Figure 1A). African and Southeast Asian
samples formed two well-separated and distinct clusters, suggesting that gene flow between the
two regions is very modest or negligible, a view supported by an alternative analysis using principal
coordinate analysis (Figure 1B). None of the African parasites carrying kelch13 mutations grouped
with the Southeast Asian population, supporting the idea that these mutations are indigenous.
We considered that recombination between African and imported parasites could result in the
transfer of DNA segments of Asian origin into genomes that otherwise appear to be local, and there-
fore not be easily detectable through genome-wide analysis. Thus, we analyzed the regions immedi-
ately flanking kelch13 in both directions, using a probabilistic method to reconstruct the most likely
geographical origin of haplotypes observed in African kelch13mutants (Figure 2). The vast majority of
kelch13 mutants showed no evidence that flanking regions may have been imported, which indicates
that most mutations observed in Africa do not have a common origin with those in Asia, and are likely
to have emerged independently on a variety of haplotypes (Figure 2—figure supplement 1).
Only 5 samples out of 56 were assigned a significant probability of Southeast Asian origin in at
least one flanking sequence, and only two of these samples carried haplotypes similar to those in
SEA mutants (Figure 2—figure supplement 2). Both in the NJ tree and in the PCA, these two Afri-
can kelch13 mutants do not cluster with the bulk of African samples, but occupy a somewhat iso-
lated position (Figure 1). We note that they exhibit unusually high levels of heterozygosity (FWS <
0.4), with mixed calls randomly distributed across the genome, consistent with a mix of African and
MalariaGEN Plasmodium falciparum Community Project. eLife 2016;5:e08714. DOI: 10.7554/eLife.08714 3 of 29
Research article Genomics and evolutionary biology Microbiology and infectious disease
SEA parasites. Continuous genetic monitoring of the parasite population will determine whether
these are indeed just isolated cases, or they constitute very early evidence of gene flow between the
two regions. Since these samples passed through a number of different laboratories, we cannot
absolutely rule out the possibility that these mixtures could be the result of biological contamination
during sample preparation and processing.
Across the genome there are many more rare variants in Africa
Historical demographic changes such as population expansions and bottlenecks (Tanabe et al.,
2010), and epidemiological and environmental factors (Prugnolle et al., 2010) are highly influential
Table 1. Count of samples analysed in this study.
Region Code Sample counts Country Code Sample counts
West Africa WAF 957 Burkina Faso BF 56
Cameroon CM 134
Ghana GH 478
Gambia, The GM 73
Guinea GN 124
Mali ML 87
Nigeria NG 5
East Africa EAF 412 Kenya KE 52
Madagascar MG 18
Malawi MW 262
Tanzania TZ 68
Uganda UG 12
Central Africa CAF 279 D. R. Congo CD 279
South America SAM 27 Colombia CO 16
Peru PE 11
South Asia SAS 75 Bangladesh BD 75
West Southeast Asia WSEA 497 Myanmar MM 111
Thailand TH 386
East Southeast Asia ESEA 1102 Cambodia KH 762
Laos LA 120
Vietnam VN 220
Oceania OCE 62 Indonesia (Papua) ID 17
Papua New Guinea PG 45
DOI: 10.7554/eLife.08714.003
Table 2. Worldwide distribution of kelch13 mutations. Number of kelch13 propeller and BTB-POZ
domain (KPBD) mutations present (not necessarily exclusively) in 5 populations (AFR = Africa,
SEA = Southeast Asia, SAS = South Asia, OCE = Oceania, SAM = South America). Sample size is
reported for each population.
AFR
(N = 1,648)
SEA
(N = 1,599)
SAS
(N = 75)
OCE
(N = 62)
SAM
(N = 27)
Non-synonymous KPBD 26 34 1 1 0
Upstream region 42 16 2 1 1
Synonymous KPBD 38 9 1 0 0
Upstream region 22 3 1 0 0
DOI: 10.7554/eLife.08714.004
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Table 3. List of non-synonymous KPBD mutations. Non-synonymous mutations found in the kelch13
propeller and BTB-POZ domains (KPBD) and their position on chromosome Pf3D7_13_v3. For each
mutation is reported where it has been observed and in how many samples. Where known, we
reported if the mutation has been previously observed in patients with a prolonged parasite
clearance half-life (>5 hr) by Miotto et al. 2014 and/or Ashley et al 2014. Sample size is reported for
each population.
Mutation
Genomic
coordinates
AFR
(N = 1,648)
SEA
(N = 1,599)
SAS
(N = 75)
OCE
(N = 62)
SAM
(N = 27)
Observed in
ART-R
samples?
D353Y 1725941 - 4 - - - Yes
F395Y 1725814 - 1 - - - No
I416V 1725752 1 1 - - -
I416M 1725750 1 - - - -
K438N 1725684 - 1 - - - No
P441L 1725676 - 27 - - - Yes
P443S 1725671 - 1 - - -
F446I 1725662 - 7 - - - Yes
G449A 1725652 - 7 - - - Yes
S459L 1725622 2 2 - - -
A481V 1725556 - 4 - - - Yes
S485N 1725544 - 1 - - -
Y493H 1725521 1 76 - - - Yes
V520I 1725440 1 - - - -
S522C 1725434 2 1 - - - Yes
P527H 1725418 1 5 - - -
C532S 1725404 1 - - - -
V534L 1725398 2 - - - -
N537I 1725388 1 1 - - - No
G538V 1725385 - 19 - - - Yes
R539T 1725382 - 63 - - - Yes
I543T 1725370 - 34 - - - Yes
P553L 1725340 2 24 - - - Yes
A557S 1725329 1 - - - -
R561H 1725316 1 24 - - - Yes
V568G 1725295 - 6 - - - Yes
T573S 1725280 2 - - - -
P574L 1725277 - 12 - - - Yes
R575K 1725274 - 3 - - -
A578S 1725266 18 - - - - No
C580Y 1725259 2 423 - 1 - Yes
D584V 1725247 - 3 - - - Yes
V589I 1725233 2 - - - -
T593S 1725221 1 - - - -
E612D 1725162 1 - - - -
Q613E 1725161 5 1 - - -
Q613L 1725160 1 - - - - No
F614L 1725158 - 1 - - - No
Y630F 1725109 2 1 - - -
Table 3 continued on next page
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forces that shaped the allele frequency spectra of P. falciparum populations across the globe
(Nielsen et al., 2009; Manske et al., 2012). In order to properly contextualize the numbers and fre-
quencies of kelch13 mutations, it is therefore important to characterize genomic variation patterns in
different geographical regions.
One of the most striking features of this dataset is the high number of rare variations in the high-
quality SNP list. At more than half of all polymorphic sites, the minor allele was only carried by a single
sample (referred to as singletons, n = 330,783 or 35%) or by two samples (doubletons, n = 214,179 or
23%), often in heterozygous calls. By contrast, only 13,383 polymorphisms (1.4%) had a minor allele in
5% of samples. Rare alleles, however, are not evenly distributed geographically. There is a large
excess of polymorphisms with minor allele frequency (MAF) below 0.1% in Africa (71% of all SNPs, vs.
17% in SEA), while numbers in the two regions are similar for SNPs with MAF>1% (2% of all SNPs,
Figure 3a). Rare variations in Africa are not confined to a limited set of highly variable genes, but
evenly distributed across the genome, as attested by the distribution of variants across all genes: SNP
density in Africa (median = 67 SNPs/kbp, interquartile range = 51–84) is approximately 3.9 times
higher than in SEA (median = 17, IQR = 13–22, p < 10–16, Figure 3b). Very similar ratios are estimated
in both non-synonymous (Africa median SNP density = 43, IQR = 27–58; SEA median = 11, IQR = 7–
15) and synonymous variants (Africa median SNP density=25, IQR = 20–30, SEA median = 6, IQR = 4–
8). Accordingly, we found virtually identical distributions of the ratio of non-synonymous to synony-
mous mutations (N/S ratio) in the two regions (Figure 3c). This suggests that the huge disparity in SNP
density between the two regions is more likely to be the result of different demographic histories and
epidemiological characteristics, such as changes in effective population size (Joy et al., 2003), rather
than the product of different selective constraints.
In summary, we observe many more rare variants in Africa than in SEA; however we expect N/S
ratios to be similar in these two regions in genes that are not subjected to selective pressures.
Comparing kelch13 with other parts of the genome
The density of kelch13 synonymous variations in the two continents is roughly consistent with that
observed in the rest of the genome (Africa: 28 SNPs/kbp, SEA: 6; Figure 4a), which is expected
since synonymous changes are less likely to be affected by selection. The excess of African non-syn-
onymous mutations in the upstream region is also consistent with expectations (Africa: 44 SNPs/kbp,
SEA: 16). In contrast, non-synonymous polymorphisms in the KPBD show a reversal of this relation-
ship: SEA parasites possess about 30% more polymorphisms than African ones (34 in SEA vs. 26 in
AFR). In addition, all but two non-synonymous changes in the KPBD are observed in Africa at very
low frequency (singletons and doubletons), while in SEA more than half of the changes are observed
in >2 samples (Table 4 and Figure 3—figure supplement 1).
At a first approximation, these observations are consistent with a high number of non-synony-
mous changes that have risen in frequency in SEA parasites because of their association with artemi-
sinin resistance, and a low number of mostly rare alleles in Africa, where artemisinin has been
introduced more recently and resistance is yet to be reported.
Table 3 continued
Mutation
Genomic
coordinates
AFR
(N = 1,648)
SEA
(N = 1,599)
SAS
(N = 75)
OCE
(N = 62)
SAM
(N = 27)
Observed in
ART-R
samples?
V637I 1725089 2 - - - -
P667A 1724999 - 2 - - -
P667L 1724998 - 2 1 - -
F673I 1724981 - 3 - - - Yes
A675V 1724974 1 18 - - - Yes
A676S 1724972 2 3 - - -
H719N 1724843 1 8 - - - Yes
DOI: 10.7554/eLife.08714.005
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Figure 1. Differentiation between African and Asian genomes. (A) Neighbour-joining tree showing population
structure across all sampling sites, with sample branches coloured according to country groupings (Table 1).
Branches with large open tip circle indicate the sample is a kelch13 mutant, while those with a small black symbol
are mixed infections (i.e. mixture of wild-type and mutant parasites or two mutant parasites with different
mutations). Branches without tip symbols are kelch13 wild type. African kelch13 mutants are, at a genomic level,
similar to other African samples. (B) Plot of second principal component (PC2) against the first (PC1), computed
from a principal coordinate analysis (PCoA) of all samples in the present study, based on the same pairwise
genetic distance matrix used for the tree of Figure 1A. PC1 clearly separates African samples from those collected
in SEA, while PC2 is mainly driven by extreme population structure in ESEA.
DOI: 10.7554/eLife.08714.006
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Figure 2. Local origin of African kelch13 mutations. (A) Chromosome painting (see Materials and methods) of the 52 African kelch13 mutants across the
two 250 kbp flanking regions on each side of the kelch13 gene. Each genome chunk is coloured according to the aggregated posterior probabilities
that it originated in the African (red) or SEA (blue) population, according to the scale shown. (B) Detail of the flanking regions over a span of
approximately 15 kbp, using the same colour scheme. The country of origin is indicated on the left, followed by the proportion of African chunks
identified; the kelch13 mutation carried by the sample is shown on the right. Samples are sorted by the proportion of Asian chunks in this window, and
the same order was applied to Panel A. Only five samples (lower region of the panel) show strong probability of Asian origin of the chunks closest to
kelch13.
DOI: 10.7554/eLife.08714.007
The following figure supplements are available for figure 2:
Figure supplement 1. Diversity within kelch13-flanking haplotypes in African mutants.
DOI: 10.7554/eLife.08714.008
Figure supplement 2. Origin of flanking haplotypes in selected African kelch13 mutants.
DOI: 10.7554/eLife.08714.009
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Figure 3. Number and density of variants in Africa and Southeast Asia. (a) Allele frequency spectrum for Africa (red) and SEA (blue). Polymorphisms
were binned by their minor allele frequency (MAF), and the counts in each bin were plotted against frequency, shown on a logarithmic scale. Although
the number of high-frequency variations is consistent between the two regions, samples from Africa possess an excess of low-frequency variations. (b)
SNP density per gene: for each gene, the number of variants found in the two regions is normalized by the length of the coding region (in kbp). African
samples have on average 3.9 times more mutations than parasites from SEA. (c) Non-synonymous/synonymous ratio per gene: ratios of non-
synonymous to synonymous mutations found per gene are similar in the two regions. To reduce artifacts due to small numbers, only genes with at least
10 SNP were considered in both analyses.
DOI: 10.7554/eLife.08714.010
The following figure supplement is available for figure 3:
Figure supplement 1. Site frequency spectrum for non-synonymous mutations in the KPBD.
DOI: 10.7554/eLife.08714.011
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Comparing kelch13 to other highly conserved genes
Although the function of kelch13 is as yet unclear, an alignment of its homologous gene sequences
in eight Plasmodium species shows that the propeller and BTB-POZ domains are part of a highly
conserved region (Figure 4b), suggesting a crucial role in parasite fitness. A reconstruction of ances-
tral alleles from this alignment suggests that P. falciparum accumulated only five conservative amino
acid changes in the kelch13 propeller domain since diverging from other species 55 Myr ago
(Escalante and Ayala, 1995) (Table 5). Given this extreme level of conservation, non-synonymous
polymorphisms may appear surprisingly numerous in the present dataset, both in SEA (n = 34) and
in Africa (n = 26). Such elevated numbers may be produced by selection processes; alternatively,
they may be present in a large neutrally-evolving population, in which low-frequency variations con-
tinually emerge, but can only be detected for a brief span of time before they are removed by
genetic drift and/or purifying selection. The question is, then, whether neutral evolution can account
for the pattern of kelch13 mutations observed here.
To answer this question, we compared patterns of kelch13 mutations to those in the rest of the P.
falciparum genome Supplementary file 1 . Since fewer non-synonymous mutations are expected in
more conserved genes, we applied genomic calibration, i.e. we stratified these analyses by evolution-
ary conservation. Each gene was assigned a conservation score determined from a sequence align-
ment of the P. falciparum gene with its P. chabaudi homologue, using a substitution matrix corrected
for the AT bias in the Pf genome (Brick and Pizzi, 2008). P. chabaudi was chosen since it was the mem-
ber of the group most differentiated from P. falciparum (rodent plasmodia) with the most complete
reference sequence. A genome-wide non-linear negative correlation between gene conservation and
Figure 4. Structure of kelch13, positioning of mutations in Africa and Southeast Asia, and sequence conservation. (a) The amino acid positions of
kelch13 polymorphisms observed in Africa (red) and SEA (blue) are shown. Coloured rectangles describe the extents of the resistance domains (BTB/
POZ: aa. 349–448; kelch propeller: aa. 443–721) and upstream region, with the locations of non-synonymous changes indicated above, and that of
synonymous changes below. Short lines represent singleton/doubleton mutations, while longer lines represent more frequent mutations. (b)
Conservation score across amino acid residues of kelch13, derived by applying a CCF53P62 matrix on alignments of the P. falciparum gene coding
sequence with its homologues in six other Plasmodium species for which high-quality sequence data were available: P. reichenowi, P. vivax, P. knowlesi,
P. yoelii, P. berghei, and P. chabaudi (see Materials and methods). Although the region below position 200 is less conserved, particularly in rodent
species (P. yoelii, berghei, and chabaudi), there is remarkably high conservation across all species over the rest of the gene, which includes the KPBD.
DOI: 10.7554/eLife.08714.012
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N/S ratio is clearly observable; this trend is almost identical in the two populations (Figure 5a).
Although kelch13 did not diverge significantly from this relationship in Africa (P = 0.2), its N/S ratio in
SEA was the highest observed at its level of conservation, far exceeding the expected ratio (P<0.001).
Accordingly, kelch13 showed the most significant difference in N/S ratios between Africa and SEA
genome-wide (3.7-fold, P = 2  10-4 by Fisher’s exact test, Figure 5b and Supplementary file 1), even
compared to other well-known drug resistance genes (Figure 5—figure supplement 1). Such unusu-
ally high N/S ratio in SEA parasites is mainly due to an excess of high frequency non-synonymous varia-
tions (Figure 5—figure supplement 2), suggesting that multiple independent origins of artemisinin
resistance (Miotto et al., 2015; Takala-Harrison et al., 2015) have produced an unusually large num-
ber of common non-synonymous mutations.
From this analysis we conclude that the high prevalence of kelch13 non-synonymous variants in
SEA is not explainable by neutral evolution, but is consistent with selection of artemisinin-resistance
alleles. In Africa, on the other hand, the observed non-synonymous changes appear to constitute a
“physiological” level of variation consistent with a population rich in low-frequency alleles.
In Southeast Asia there are more radical substitutions in kelch13
The different kelch13 mutation repertoires in Africa and in SEA raise the question of whether these
sets of mutations have different structural and functional properties. While there is high conservation
across the whole of the propeller domain, it is unlikely that all possible amino acid changes have the
same functional relevance or that they all carry the same fitness cost for parasites. Although direct
measures of functional relevance are not yet available, and the exact function of kelch13 is hitherto
unknown, we can make statistical comparisons of some properties of the observed changes, in at
least two respects. First, assuming that kelch13 function is conserved across Plasmodium species, we
can assess the strength of evolutionary constraints at any given position by examining whether
amino acid substitutions between species are conservative or radical. Second, given that kelch pro-
teins have been shown in other organisms to play an adapter role, with key binding sites defined by
the arrangement of hydrophobic b-strands in the propeller domain (Adams et al., 2000), we can
assess changes in hydrophobicity caused by the observed mutations, which may be informative of
their functional importance.
Detailed mapping against the secondary structure of the propeller domain suggests that the
polymorphisms found in SEA parasites occur in different blades, preferentially at positions proximal
to the first and second b-strand of the propeller’s blades (Figure 6). This may indicate that these
two strands play a role in defining the binding interface to the PI3K protein involved in artemisinin
resistance (Mbengue et al., 2015), but this needs to be confirmed by in-depth structural analyses.
We characterized changes in the propeller domain by a conservation score derived from a substi-
tution matrix specific to AT-rich genomes (Brick and Pizzi, 2008), and assigned a hydrophobicity
score to each site, estimated from the Kyte-Doolittle (KD) hydropathicity score (Kyte and Doolittle,
1982). The five putative derived alleles that have become established in the P. falciparum kelch13
propeller domain since its divergence from other Plasmodia are all conservative changes at hydro-
philic sites (Figure 6—figure supplement 1a). Common mutations in Africa have characteristics
broadly consistent with this conservative history of change (Figure 6—figure supplement 1b and
Table 6). Polymorphisms in SEA parasites, on the other hand, show a pattern of changes that are
Table 4. Frequency of the non-synonymous KPBD mutations. Counts of non-synonymous mutations
in the conserved propeller and BTB-POZ domains of kelch13 are shown for each geographical
region, stratified by the number of samples in which they are observed. Sample size for each
population is reported.
AFR
(N = 1,648)
SEA
(N = 1,599)
SAS
(N = 75)
OCE
(N = 62)
SAM
(N = 27)
1–2 samples 24 13 1 1 0
3–5 samples 1 7 0 0 0
>5 samples 1 14 0 0 0
DOI: 10.7554/eLife.08714.013
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more radical than those in Africa (P = 10–3) and more commonly found at hydrophobic sites (Fig-
ure 6—figure supplement 1c and Table 6).
Taken together, the above results suggest that the propeller domain has long been under very
strong evolutionary constraints, and that the number and nature of the changes observed in African
parasites is consistent with these constraints, once we discard the abundant rare alleles expected in
such a large population. In contrast, mutations in SEA parasites are not only far more numerous than
expected, but they produce radical changes that are likely to be important determinants of the bind-
ing properties of the kelch13 protein, consistent with recent findings that binding of kelch13 to the
PI3K protein is a critical factor in P. falciparum response to artemisinin (Mbengue et al., 2015).
Genetic background
A recent study has shown that resistance-causing KPBD mutations are significantly more likely to
arise in parasites with a particular genetic background (Miotto et al., 2015). This predisposing
genetic background is marked by specific SNP alleles of the genes encoding ferredoxin (fd), apico-
plast ribosomal protein S10 (arps10), multidrug resistance protein 2 (mdr2) and chloroquine
Table 5. Kelch13 propeller domain mutations in different Plasmodium species. Here we report amino acid allele differences in a
multiple sequence alignments of kelch13 homologues for seven species of Plasmodium parasites for which high-quality sequence data
were available: P. falciparum (Pf), P. reichenowi (Pr), P. vivax (Pv), P. knowlesi (Pk), P. yoelii (Py), P. berghei (Pb), and P. chabaudi (Pc).
The species formed three groups by similarity: Laverania (Pf, Pr), primate Plasmodia (Pv, Pk) and rodent Plasmodia (Py, Pb and Pc). An
allele shared by all members of two different groups was identified as a putative ancestral allele. The table shows, for each position
where at least one species exhibits a difference from the others: the amino acid position in the Pf kelch13 sequence; the putative
ancestral amino acid allele; the alleles in the various species (columns with heading listing multiple species show mutations common
to those species); and a substitution score of the mutation, based on a CCF53P62 substitution matrix (see Materials and methods). All
substitution scores are 0, denoting conservative substitutions.
Pf Position Ancestral Allele Pf,Pr Pv,Pk Pk Py,Pb,Pc Py,Pb Pb Pc Substitution Score
434 F - - - - - - Y 2
447 C - - - - S - - 1
448 I - M - - - - - 2
517 T V - - - - - - 0
519 F Y - - - - - - 2
520 V - - - L - - - 0
534 V - - - I - - - 2
550 S - - C - - - - 1
566 V - - - I - - - 2
568 V - I - - - - - 2
578 A - S - - - - - 0
584 D - - E - - - - 1
590 I - - - - V - - 2
593 T - - - A - - - 0
605 D E - - - - - - 1
613 Q - - - - N - K 0
648 D - - - E - - - 1
666 V - - - I - - - 2
676 A - - - T - - - 0
691 D E - - - - - - 1
708 I L - - - - - - 0
711 S - - - - - P - 0
723 I - - - V - - - 2
DOI: 10.7554/eLife.08714.014
MalariaGEN Plasmodium falciparum Community Project. eLife 2016;5:e08714. DOI: 10.7554/eLife.08714 12 of 29
Research article Genomics and evolutionary biology Microbiology and infectious disease
Figure 5. Genome-wide analysis of N/S ratio. (a) For each gene with more than 2 synonymous or non-synonymous SNPs, the N/S ratio in Africa (red
points) and in SEA (blue points) are plotted against the conservation score of the gene coding sequence. The kelch13 gene values are represented by
larger circles. For each region, a solid line show median values, while dotted lines delimit 95% of the genes at varying levels of conservation. This plot is
truncated on the y-axis to show more clearly the bulk of the distribution; the full range is shown in Figure 5—figure supplement 2. (b) Histogram
showing the distribution of the ratio of N/S ratios in SEA and Africa, for all genes with 5 synonymous and 5 non-synonymous SNPs on each region.
An arrow shows the placement of kelch13.
DOI: 10.7554/eLife.08714.015
The following figure supplements are available for figure 5:
Figure supplement 1. N/S ratio of well-known drug resistance genes.
DOI: 10.7554/eLife.08714.016
Figure supplement 2. Genome-wide analysis of high-frequency SNP density.
DOI: 10.7554/eLife.08714.017
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resistance transporter (crt). Here we extend this analysis, confirming that this particular combination
of variants is extremely common in the parts of Southeast Asia where artemisinin resistance is known
to be established, and is absent from Africa and other regions sampled here (Table 7).
Discussion
This study demonstrates the value of genomic data in characterising the current epidemic of artemi-
sinin resistance, which is problematic for conventional molecular epidemiology since new resistance-
causing mutations are continually emerging on different haplotypic backgrounds. A key problem is
to define the geographical origin of KBPD mutations, and we show that this can be solved by using
genomic epidemiological data to analyse ancestral relationships between samples, thereby demon-
strating that the KPBD mutations observed in Africa are of local origin.
Figure 6. Structure of the kelch13 propeller domain, showing the position of mutations in Southeast Asia and Africa. The sequence of the kelch13
propeller domain (amino acids 443–726) is organized according to its 6-blade tertiary structure, with the four b-strands characterizing each blade
highlighted in colour. Polymorphisms observed in SEA (top panel) and Africa (bottom panel) are shown by circles above the mutated position. Small
circles indicate very rare mutations (singletons and doubletons), while larger circles are used for more frequent mutations.
DOI: 10.7554/eLife.08714.018
The following figure supplement is available for figure 6:
Figure supplement 1. Characterization of kelch13 mutations in Africa and Southeast Asia.
DOI: 10.7554/eLife.08714.019
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Table 6. Conservation score of KPBD mutations.The table shows, for each non-synonymous KPBD
mutation observed in the dataset, the number of samples carrying the mutation in Africa (AFR), in
Southeast Asia (SEA), and a substitution score of the mutation, based on a CCF53P62 substitution
matrix; lower values indicate more radical substitutions. Mutations observed in Africa tend to have
higher conservation score, whereas in SEA mutations tend to be more radical.
Mutation AFR SEA CFF53P62
Q613E 5 1 2
Y630F 2 1 2
V637I 2 0 2
V589I 2 0 2
T573S 2 0 2
Y493H 1 76 2
I416V 1 1 2
T593S 1 0 2
V520I 1 0 2
I416M 1 0 2
F395Y 0 1 2
S522C 2 1 1
E612D 1 0 1
C532S 1 0 1
R575K 0 3 1
A578S 18 0 0
A676S 2 3 0
V534L 2 0 0
R561H 1 24 0
A675V 1 18 0
H719N 1 8 0
P527H 1 5 0
A557S 1 0 0
R539T 0 63 0
I543T 0 34 0
G449A 0 7 0
F446I 0 7 0
A481V 0 4 0
F673I 0 3 0
P667A 0 2 0
F614L 0 1 0
S485N 0 1 0
P443S 0 1 0
C580Y 2 423 -2
D353Y 0 4 -2
K438N 0 1 -2
P553L 2 24 -3
P441L 0 27 -3
G538V 0 19 -3
P574L 0 12 -3
V568G 0 6 -3
Table 6 continued on next page
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Another important question is whether KPBD mutations are under positive selection in Africa,
which is difficult to determine by standard haplotype-based methods because so many independent
mutations are involved. This question is further complicated by marked geographical variation in nor-
mal levels of genetic diversity, i.e. there are many more rare variants in Africa than Southeast Asia,
most likely due to the larger population size and other demographic factors (Manske et al., 2012).
Here we address this question by comparing kelch13 against other genes in the same samples, a
process that we refer to as genomic calibration. We show that for most genes the ratio of non-syn-
onymous to synonymous mutations is relatively constant across geographical regions, despite geo-
graphic differences in genetic diversity, and that this ratio is correlated with the level of sequence
conservation across different Plasmodium species. When calibrated against other genes with the
same level of cross-species conservation, allowing for geographical differences in the overall level of
genetic diversity, kelch13 shows a marked excess of non-synonymous substitutions in Southeast
Asia, but appears normal in Africa. Moreover, KPBD mutations causing radical amino acid changes
at highly conserved positions are found at relatively high frequency in Southeast Asia but remain at
very low frequency in Africa. Taken together, these findings indicate that non-synonymous KBPD
mutations are undergoing strong evolutionary selection in Southeast Asia, whereas those seen in
Africa have originated locally and most likely reflect normal variation.
These findings have practical implications for the prevention of artemisinin resistance in Africa,
where there is evidently a deep reservoir of low frequency genetic variations that could potentially
allow resistance to emerge rapidly as the levels of selective pressure increase. In most parts of
Africa, the selective pressure of artemisinin is probably relatively low at present, for several reasons.
Artemisinin has been widely used in Southeast Asia for over two decades, whereas its usage in Africa
is more recent, and it is estimated that only 20% of infected African children currently have access to
frontline treatment ACT medication (World Health Organization, 2014b). Another factor is that
people living in regions of high malaria endemicity acquire partial immunity, resulting in asymptom-
atic infection, so that there is a large reservoir of parasites in Africa that are not exposed to antima-
larial drugs because asymptomatic individuals do not seek treatment (Hastings, 2003). The situation
could change dramatically as malaria control efforts are intensified, and it will be vital to monitor the
effects of major interventions on the emergence of resistance, particularly in African countries that
have already achieved relatively low levels of malaria transmission. A key question for the future is
whether parasite populations in certain locations possess genetic features that predispose to the
emergence of artemisinin resistance, as suggested by the strong association of certain fd, arps10,
mdr2 and crt alleles with resistance-causing KPBD mutations in Southeast Asia (Miotto et al., 2015).
Table 6 continued
Mutation AFR SEA CFF53P62
P667L 0 2 -3
S459L 2 2 -4
N537I 1 1 -4
Q613L 1 0 -4
D584V 0 3 -5
DOI: 10.7554/eLife.08714.020
Table 7. Frequency of the genetic background alleles across the world. Frequency of the four genetic background alleles identified in
Miotto et al. (2015) for each geographical region. For each SNP, we show mutation name; chromosome number; nucleotide
position; and frequencies of the mutant allele in the various populations.
Mutation Chr Pos AFR SAS SEA PNG SAM
arps10-V127M 14 2481070 0.0% 0.0% 59.4% 0.0% 0.0%
fd-D193Y 13 748395 0.1% 2.2% 62.8% 23.9% 0.0%
mdr2-T484I 14 1956225 0.1% 5.7% 64.2% 0.4% 0.0%
crt-N326S 7 405362 0.8% 28.2% 68.6% 0.1% 0.0%
DOI: 10.7554/eLife.08714.021
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Another concern is that growing resistance to ACT partner drugs, now emerging in Southeast Asia
(Saunders et al., 2014) may spread to Africa, or evolve independently there, and lead to increased
selective pressure for artemisinin resistance there.
The global spread of resistance to chloroquine and sulfadoxine-pyrimethamine was dominated by
hard sweeps of specific haplotypes originating in Southeast Asia, although it is clear that there were
also localised emergences (Mita et al., 2009). Although we still know relatively little about the func-
tional properties of different KPBD mutations, it is clear that some are more successful than others,
e.g. the C580Y allele has emerged at multiple locations in Southeast Asia and Africa, and a specific
C580Y haplotype is approaching fixation in large parts of Western Cambodia (Miotto et al., 2015).
The high level of sequence conservation of KPBD across Plasmodium species indicates that muta-
tions in these domains incur fitness costs, and this is supported by the observation that although
there have been multiple independent origins of resistance-causing kelch13 mutations, individual
kelch13 mutations appear to have limited spread, implying that there is a substantial fitness cost in
the absence of sustained drug pressure. The danger is that these fitness costs may be compensated
by other genetic variants, either in kelch13 or elsewhere in the genome, and that, as a result of this
continuing evolutionary process, parasites in Southeast Asia will progressively acquire higher levels
of artemisinin resistance (World Health Organization, 2014a) coupled with strong biological fitness
and the ability to propagate across a wide range of vector species. Under these circumstances, the
current soft sweep of artemisinin resistance could give way to a pervasive hard sweep with poten-
tially disastrous consequences.
These findings demonstrate the utility of applying genomic epidemiology to identify features of
parasite demography and evolution that affect how drug resistance spreads. Future strategies to
combat resistance will require better understanding of the evolutionary consequences of malaria
control interventions, e.g. how the selective advantage of a resistance allele is counterbalanced by
its fitness cost under different control regimes and in different geographical settings. It is now possi-
ble to approach this problem prospectively, by conducting systematic spatiotemporal sampling and
genome sequencing of the parasite population as an integral part of public health interventions to
prevent resistance spreading.
Materials and methods
Ethical approval
All samples in this study were derived from blood samples obtained from patients with P. falciparum
malaria, collected with informed consent from the patient or a parent or guardian. At each location,
sample collection was approved by the appropriate local and institutional ethics committees. The
following local and institutional committees that gave ethical approval for the partner studies: Com-
ite´ d’E´thique, Ministe`re de la Sante´, Bobo-Dioulasso, Burkina Faso; Navrongo Health Research Cen-
tre Institutional Review Board, Navrongo, Ghana; Kintampo Health Research Centre Institutional
Ethics Committee, Kintampo, Ghana; Noguchi Memorial Institute for Medical Research Institutional
Review Committee, University of Ghana, Legon, Ghana; Ghana Health Service Ethical Review Com-
mittee, Accra, Ghana; Gambia Government/MRC Joint Ethics Committee, Banjul, The Gambia; Com-
ite´ d’Ethique National Pour la Recherche en Sante´, Guinea; Ethics Committee of Faculte´ de
Me´decine, de Pharmacie et d’Odonto-Stomatologie, University of Bamako, Bamako, Mali; Ethical
Review Committee, University of Ilorin Teaching Hospital, Ilorin, Nigeria; Institutional Review Board,
Faculty of Health Sciences, University of Buea, Cameroon; Comite´ d’Ethique, Ecole de Sante´ Publi-
que, Universite´ de Kinshasa, Ministe`re de l’Enseignement Superieur, Universitaire et Recherche Sci-
entifique, D. R. Congo; Comite´ National d’Ethique aupre`s du Ministe`re de la Sante´ Publique,
Madagascar; Institutional Review Committee, Med Biotech Laboratories, Kampala, Uganda and
Uganda National Council for Sciences and Technology (UNCST); College of Medicine Research
Ethics Committee, University of Malawi, Blantyre, Malawi; KEMRI National Ethical Review Commit-
tee, Kenya; Medical Research Coordinating Committee of the National Institute for Medical
Research, Tanzania; Ethical Review Committee, Bangladesh Medical Research Council, Bangladesh;
Ethics Committee of the International Centre for Diarrheal Disease Research, Bangladesh; Institu-
tional Ethical Review Committee, Department of Medical Research (Lower Myanmar); Ministry of
Health, Government of The Republic of the Union of Myanmar; National Ethics Committee for
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Health Research, Ministry of Health, Phnom Penh, Cambodia; Ministry of Health National Ethics
Committee For Health Research, Laos; Ethics Committee, Faculty of Tropical Medicine, Mahidol Uni-
versity, Bangkok, Thailand; Ethical Committee, Hospital for Tropical Diseases, Ho Chi Minh City,
Vietnam; Eijkman Institute Research Ethics Commission, Jakarta, Indonesia; Institutional Review
Board, Papua New Guinea Institute of Medical Research, Goroka, Papua New Guinea; Institutional
Review Board, International Center for Medical Research and Training, Cali, Colombia; Institutional
Review Board, Universidad Nacional de la Amazonia Peruana, Iquitos, Peru; Human Research Ethics
Committee of NT Department of Health and Families and Menzies School of Health Research, Dar-
win, Australia; Institutional Review Board, New York University Medical School, NY, USA; Institutional
Review Board, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA; Institutional
Review Board, Walter Reed Army Institute of Research, Washington DC, USA; Ethics Review Com-
mittee, World Health Organization, Geneva, Switzerland; Ethics Committee of the Faculty of Medi-
cine, Heidelberg, Germany; Ethics Committee of the Medical University of Vienna; Ethics
Committee, London School of Hygiene and Tropical Medicine, London, UK; Oxford Tropical
Research Ethics Committee, Oxford, UK.
Sample preparation, sequencing and genotyping
DNA was extracted directly from blood samples taken from patients at admission time, after leuko-
cyte depletion to minimize human DNA. Leukocyte depletion was achieved by CF11 filtration in
most samples (Venkatesan et al., 2012), or alternatively by Lymphoprep density gradient centrifu-
gation (Axis-Shield, Dundee, UK) followed by Plasmodipur filtration (Euro-Diagnostica, Malmo¨, Swe-
den) (Auburn et al., 2011) or by Plasmodipur filtration alone. Genomic DNA was extracted using
the QIAamp DNA Blood Midi or Maxi Kit (Qiagen, Hilden, Germany), and quantities of human and
Plasmodium DNA were determined by fluorescence analysis using a Qubit instrument
(Invitrogen, Carlsbad, California) and multi-species quantitative PCR (Q-PCR) using the Roche Light-
cycler 480 II system, as described previously (Manske et al., 2012). Samples with >50 ng DNA and
<80% human DNA contamination were selected for sequencing on the Illumina HiSeq platform fol-
lowing the manufacturer’s standard protocols (Bentley et al., 2008). Paired-end sequencing reads
of length 200–300 bp were obtained, generating approximately 1 Gbp of read data per sample. All
short read sequence data have been deposited in the European Nucleotide Archive (http://www.ebi.
ac.uk/ena/data/search/?query=plasmodium), and metadata will be released at the time of
publication.
Polymorphism discovery, quality control and sample genotyping followed a process described
elsewhere (Manske et al., 2012). Short sequence reads from 3,411 P. falciparum samples included
in the MalariaGEN Plasmodium falciparum Community Project (http://www.malariagen.net/projects/
parasite/pf) were aligned against the P. falciparum 3D7 reference sequence V3 (ftp://ftp.sanger.ac.
uk/pub/pathogens/Plasmodium/falciparum/3D7/3D7.latest_version/version3/), using the bwa
program (Li and Durbin, 2009) (http://bio-bwa.sourceforge.net/) as previously
described (Manske et al., 2012), to identify an initial global set of 4,305,957 potential SNPs. This list
was then used to guide stringent re-alignment using the SNP-o-matic algorithm (Manske and Kwiat-
kowski, 2009), to reduce misalignment errors. The stringent alignments were then examined by a
series of quality filters, with the aim of removing alignment artefacts and their sources. In particular,
the following were removed: a) non-coding SNPs; b) SNPs where polymorphisms have extremely
low support (<10 reads in one sample); c) SNPs with more than two alleles, with the exception of
loci known to be important for drug resistance, which were manually verified for artifacts; d) SNPs
where coverage across samples is lower than the 25th percentile and higher than the 95th percentile
of coverage in coding SNPs (these thresholds were determined from artifact analysis); e) SNPs
located in regions of relatively low uniqueness (Manske et al., 2012); f) SNPs where heterozygosity
levels were found to be inconsistent with the heterozygosity distribution at the SNP’s allele fre-
quency; and g) SNPs where genotype could not be established in at least 70% of the samples. These
analyses produced a final list of 935,601 high-quality SNPs in the 14 chromosomes of the nuclear
genome, whose genotypes were used for analysis in this study.
All samples were genotyped at each high-quality SNP by a single allele, based on the number of
reads observed for the two alleles at that position in the sample. At positions with fewer than 5
reads, the genotype was undetermined (no call was made). At all other positions, the sample was
determined to be heterozygous if both alleles were each observed in more than 2 reads; otherwise,
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the sample was called as homozygous for the allele observed in the majority of reads. For the pur-
poses of estimating allele frequencies and genetic distances, a within-sample allele frequency (fw)
was also assigned to each valid call. For heterozygous calls, fw was estimated as ratio of non-refer-
ence read count to reference read count; homozygous calls were assigned fw = 0 when called with
the reference allele, and fw = 1 when called with the non-reference allele.
The genotype of kelch13 was derived from read counts at non-synonymous SNP in the KPBD
using a procedure described previously (Miotto et al., 2015)
Frequency estimation and clustering
For a given population P, we estimated the non-reference allele frequency (NRAF) at a given SNP as
the mean of the within-sample allele frequency (fw) for all samples in P which have a valid genotype
at that SNP. The minor allele frequency (MAF) at is the computed as min(NRAF, (1 – NRAF)).
To investigate the global population structure, we started by computing an NxN pairwise dis-
tance matrix, where N is the number of samples. Each cell of the matrix contained an estimate of
genetic distance between the relevant pair of samples, obtained by summing the pairwise distance,
estimated from within-sample allele frequency (fw), at each SNP in the 100 kbp window considered.
When comparing a pair of samples sA and sB at a single SNP i where a genotype could be called in
each sample, with within-sample allele frequencies fA and fB respectively, the distance dAB was esti-
mated as dAB = fA (1- fB) + fB(1- fA). The genome-wide distance DAB between the two samples is
then calculated as
DAB ¼
a
nAB
X
i
widAB
where nAB is the number of SNPs where both samples could be genotyped, wi is an LD weighting
factor (see below) and a is a scaling constant, equal to 70% of the number of coding positions in the
genome (since our genotyping covers approximately 70% of the coding genome). The exact value of
a is uninfluential towards the analyses conducted in this study. The LD weighting factor, which cor-
rects for the cumulative contribution of physically linked polymorphisms, was computed at each SNP
i with MAF  0.1 in our sample set, by considering a window of m SNPs (j = 0.. m) centred at i. For
each j, we computed the squared correlation coefficient r2ij between SNPs i and j. Ignoring positions
j where where r2ij < 0.1, the weighting wi was computed by
wi ¼
1
1þ
P
j r
2
ij
A neighbour-joining tree was then produced using the nj implementation in the R ape package.
Principal coordinate analysis (PCoA) was performed using the same pairwise distance matrices using
the Classical Multidimensional Scaling (MDS) method (Gower, 1966) PCoA is a computationally effi-
cient variant of principal component analysis (PCA) in which a pairwise distance matrix is used as
input, rather than a table of genotypes. The matrix was supplied as input to the MDS algorithm,
using the R language cmdscale implementation.
Conservation scoring and ancestral allele analysis
We analyzed homologous protein sequences of kelch13 genes for seven Plasmodium species for
which high-quality sequence data were available: P. falciparum, P. reichenowi, P. vivax, P. knowlesi,
P. yoelii, P. berghei, and P. chabaudi. The sequences were retrieved from the OrthoMCL cluster
ORTHOMCL894 in GeneDB (http://www.genedb.org/), and a multiple alignment was obtained using
ClustalW (Larkin et al., 2007) at default settings. In turn, we considered each pair alignment of P.
falciparum with one of the remaining species, assigning a substitution score to each kelch13 amino
acid position, derived from the CCF53P62 substitution matrix. Although this matrix was chosen due
to its suitability for AT-rich codon biases (Brick and Pizzi, 2008), we found that use of the more
commonly used BLOSUM62 matrix (Henikoff and Henikoff, 1992) did not have a significant effect
on the results. Finally, each amino acid position was assigned a conservation score for the pair align-
ment, equal to the mean of the substitution scores in a 9-residue window centered at that position.
To reconstruct putative ancestral and derived alleles in the propeller domain, we catalogued all
polymorphic positions in the multiple sequence alignment. We organized the seven species into
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three groups by similarity: Laverania (P. falciparum, P. reichenowi), primate Plasmodia (P. vivax, P.
knowlesi) and rodent Plasmodia (P. yoelii, P. berghei, and P. chabaudi), and observed that at each
position, only one of the groups presented an allele different from that in the remaining groups. This
group-specific allele was labelled as a putative derived allele, and the alternative allele as ancestral.
(see Table 5). Rodent species were found to carry the highest number of derived alleles, and there-
fore deemed to be good comparators for genome-wide conservation scoring. P. chabaudi was
selected as a representative species in this group, and used for subsequent comparative analyses.
We estimated a gene conservation score for every P. falciparum gene for which a P. chabaudi ortho-
logue sequence could be obtained from PlasmoDB (http://www.plasmodb.org/). The details of the
method are described elsewhere (Gardner et al., 2011). Briefly, alignments of orthologous protein
sequences were performed using ClustalW (Larkin et al., 2007) at default settings, and each amino
acid position was assigned a CCF53P62 substitution score (see above). The gene conservation score
assigned was equal to the mean substitution score for all amino acid positions in the gene.
Hydrophobicity analysis
Each amino acid position in the kelch13 was assigned a hydrophobicity score, estimated by comput-
ing the mean of the Kyte-Doolittle index in a 14-residue window centered at the position, using the
protein sequence translated from the 3D7 reference sequence.
Chromosome painting
To reconstruct the probable origin of kelch13 flanking haplotypes in African mutants, we used chro-
mosome painting (Lawson et al., 2012), a method that compares haplotypes in a sample to those in
the remaining samples, and estimates probabilities that a genome fragment originates each popula-
tion, by identifying individuals that share the same haplotype. For all African and SEA samples, we
applied chromosome painting across the 250 kbp flanking regions on each side of the kelch13 gene.
For each sample, haplotypes surrounding genome loci (chunks) were assigned posterior copying
probabilities with respect to all remaining samples (unrestricted painting). We aggregated these
probabilities according to the geographical origin of the donor samples, assigning to each chunk a
probability that it originates from each of the populations. For each sample, we then estimated the
expected fraction of chunks copied from each population.
In this analysis, we assumed a mutation rate per base per generation of 3.9-10 (Claessens et al.,
2014) and a uniform recombination map. Since the two populations differ substantially in effective
recombination rates (Mu et al., 2005), we assumed a conservative recombination rate of 30 kbp/cM.
Effective population size was initially set to 10,000 and optimized by 10 iterations of the expecta-
tion-maximization procedure (Lawson et al., 2012). To account for the presence of heterozygous
genotypes due to mixed infections, we modified the matrix of emission probabilities by introducing
a novel parameter (e, set to 10-8) to represent the probability of emitting a mixed call. We repeated
the analysis varying this parameter set, to assess the effects of misspecification, and results were
found to be very similar qualitatively (data not shown).
Data access and URLs
Illumina sequence reads have been submitted to the European Nucleotide Archive with study acces-
sions ERP000190 (www.ebi.ac.uk/ena/data/view/ERP000190) and ERP000197 (www.ebi.ac.uk/ena/
data/view/ERP000197). ENA accession numbers and metadata for the samples used in this paper
can obtained via the MalariaGEN website, which also provides access to genotype calls on individual
samples (www.malariagen.net/resource/16). Further details of all SNPs reported in this dataset
including their genome coverage, mapping quality and allele frequencies in different populations,
together with tools for querying the data, can be explored at www.malariagen.net/apps/pf.
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